期刊文献+

Epstein-Barr病毒与肝损伤相关性的研究进展

Research progress on Epstein-Barr virus-related liver injury
下载PDF
导出
摘要 EB病毒(Epstein-Barr Virus,EBV)作为常见的非嗜肝DNA病毒之一,早已被研究证实可以导致肝脏损伤(Liver injury)并引起肝功能异常,且已成为临床医生对肝功能异常患者筛查的重要指标之一。但目前尚缺乏对既往有关其感染所致肝损伤的研究成果的有效整合。本文通过梳理相关文献系统、全面探讨EBV与肝损伤相关性的研究进展,包括EBV概述、感染的现状、传播方式、所致疾病类型、其致肝损伤可能的机制和对临床诊疗的影响及EBV相关性肝损伤未来的研究方向。本文表明EBV感染所致肝损伤可能持续存在并导致严重后果,为全球带来巨大的疾病负担。因此,临床医生必须对其予以足够的重视,以期早期识别,并尽早采取有效措施使患者能最大获益。 Epstein-Barr Virus(EBV),a common non-hepatophil DNA viruses,has long been confirmed to cause liver injury and liver abnormalities,and it has become an important indicators for clinicians to screen patients with liver function abnormalities.However,There is a lack of effective integration in the past research results of EBV-related liver injury.This systematic paper comprehensively discussed the research progress of EBV-related liver injury by combing relevant literature,including the overview of EBV,infection status,transmission mode,disease types,the possible mechanism of liver injury and its influence on clinical diagnosis and treatment,as well as the future research direction of EBV-related liver injury.This study suggests that EBV-related liver damage might be persistent and have serious consequences,resulting in a significant global disease burden.Therefore,clinicians must pay enough attention for identifying it early,and taking effective measures as soon as possible to maximize the benefit of patients.
作者 刘伟强 罗红春 LIU Weiqiang;LUO Hongchun(Department of Infectious Diseases,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处 《河北医药》 CAS 2024年第10期1560-1564,共5页 Hebei Medical Journal
基金 重庆市科卫联合医学科研项目(编号:2020MSXM099)。
关键词 肝损伤 EPSTEIN-BARR病毒 诊断 治疗 致病机制 liver injury Epstein-Barr Virus Diagnosis Therapy Mechanisms of pathogenicity
  • 相关文献

参考文献2

二级参考文献39

  • 1[1]Rickinson AB,Kieff E.Epsterin-Barr virus.In:Knipe DM,Howley PM,eds.Field's Virology 4th ed.Vol.2,Philadelphia:Lippincott Williams & Wilkins,2001:2575-2627
  • 2[2]Cohen JI.Epstein-Barr virus infection.N Engl J Med 2000; 343:481-492
  • 3[3]Kimura H,Hoshino Y,Kanegane H,Tsuge I,Okamura T,Kawa K,Morishima T.Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.Blood 2001; 98:280-286
  • 4[4]Kimura H,Morishima T,Kanegane H,Ohga S,Hoshino Y,Maeda A,Imai S,Okano M,Morio T,Yokota S,Tsuchiya S,Yachie A,Imashuku S,Kawa K,Wakiguchi H.Prognostic factors for chronic active Epstein-Barr virus infection.J Infect Dis 2003; 187:527-533
  • 5[5]Straus SE.The chronic mononucleosis syndrome.J Infect Dis 1988; 157:405-412
  • 6[6]Katano H,Ali MA,Patera AC,Catalfamo M,Jaffe ES,Kimura H,Dale JK,Straus SE,Cohen JI.Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation.Blood 2004; 103:1244-1252
  • 7[7]Kimura H,Nagasaka T,Hoshino Y,Hayashi N,Tanaka N,Xu JL,Kuzushima K,Morishima T.Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes.Hum Pathol 2001; 32:757-762
  • 8[8]White NJ,Juel-Jensen BE.Infectious mononucleosis hepatitis.Semin Liver Dis 1984; 4:301-306
  • 9[9]Bertolini L,Iacovacci S,Bosman C,Carloni G,Monaco V,Bangrazi C,Serafino A,Gualandi G,Prantera G,Fruscalzo A.Low cell dosage of lymphoblastoid human cell lines EBV(+) is associated to chronic hepatitis in a minority of inoculated Nu/Nu mice.JMed Virol 2002; 66:70-81
  • 10[10]Catalina MD,Sullivan JL,Bak KR,Luzuriaga K.Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.J Immunol 2001; 167:4450-4457

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部